M. Stuschke et al., HETEROGENEITY IN THE FRACTIONATION SENSITIVITIES OF HUMAN TUMOR-CELL LINES - STUDIES IN A 3-DIMENSIONAL MODEL SYSTEM, International journal of radiation oncology, biology, physics, 32(2), 1995, pp. 395-408
Citations number
81
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Current concepts to optimize the therapeutic gain of radiothe
rapy by hyperfractionation assume that human tumors are less sensitive
to fractionation than late reacting normal tissues. The aim of this s
tudy was to investigate the extent of the intercell line heterogeneity
of fractionation sensitivity of a wide variety of human tumor cell li
nes in a three-dimensional model system under fully oxic conditions us
ing schedules with one to eight fractions. Biological characteristics
of the tumors that correlate with fractionation sensitivity should be
identified. Methods and Materials: A total of 21 cell lines from human
tumors maintained as multicellular spheroids consisting of 1000-1500
cells were given fractionated irradiation within a total treatment tim
e of maximally 50 h. Complete dose-spheroid control curves were determ
ined for each fractionation scheme. The spheroid control data were ade
quately described by the linear quadratic model assuming Poisson stati
stics. In addition, the induction of a G2 block by a fractionated test
dose of seven 3 Gy fractions given at 6-h intervals was determined in
spheroid cells using how cytometry of propidium bromide stained cell
nuclei. Results: The fractionation sensitivities of human turner cells
in multicellular spheroids could be characterized by alpha/beta value
s, ranging from 2.8-37 Gy in dependence on the cell line. The log norm
ally distributed alpha/beta values were positively correlated with the
percentage increase in G2/M phase after the fractionated test dose co
mpared to the controls (r = 0.72, p < 0.01), and were associated with
the degree of tumor differentiation (p = 0.01, ANOVA F-test). No signi
ficant correlation between the log (alpha/beta) values and the survivi
ng fractions at 2 Gy (SF2) or the total doses with 2 Gy per fraction n
ecessary to control 50% of the spheroids (SCD50) was observed. Despite
the intercell line variability of the alpha/beta values, the SCD50 va
lues of the different cell lines, given with one and eight fractions o
r one fraction and 2 Gy per fraction, were closely associated (Spearma
n rank correlation coefficients: r = 0.89 or r = 0.90, p < 0.0001). Co
nclusion: Human tumor cell lines showed a marked heterogeneity in the
fractionation sensitivity when irradiated as multicellular spheroids a
nd assayed lit situ using the spheroid control end point. Therefore, t
he therapeutic gain of altered fractionation also depends on those bio
logical characteristics of each individual tumor that affects its frac
tionation sensitivity. Parameters that correlate with fractionation se
nsitivity of the tumor lines in the spheroid system were identified as
grade of tumor differentiation and percentage increase in G2/M cells
at the end of an eight-fraction schedule.